Liposome encapsulated mitoxantrone

Drug Profile

Liposome encapsulated mitoxantrone

Alternative Names: LEM; LEM ETU; Liposomal mitoxantrone; Mitoxantrone liposomal

Latest Information Update: 19 Oct 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NeoPharm Inc
  • Class Anthraquinones; Antineoplastics
  • Mechanism of Action DNA inhibitors; DNA topoisomerase inhibitors; Immunosuppressants; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Leukaemia; Multiple sclerosis; Solid tumours

Most Recent Events

  • 09 Jun 2003 Data presented at the 39th Annual Meeting of the American Society of Clinical Oncology have been added to the adverse events and Cancer therapeutic trials section ,
  • 02 Dec 2002 A preclinical study has been added to the pharmacokinetics section
  • 26 Nov 2002 A study has been added to the adverse events and Cancer therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top